Lazard Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $21K | Sell |
588
-33,455
| -98% | -$1.19M | ﹤0.01% | 2120 |
|
2025
Q1 | $1.23M | Buy |
34,043
+34,029
| +243,064% | +$1.23M | ﹤0.01% | 1143 |
|
2024
Q4 | $0 | Sell |
14
-18,700
| -100% | – | ﹤0.01% | 2490 |
|
2024
Q3 | $1.04M | Buy |
18,714
+18,677
| +50,478% | +$1.04M | ﹤0.01% | 1062 |
|
2024
Q2 | $0 | Sell |
37
-4,123
| -99% | – | ﹤0.01% | 2392 |
|
2024
Q1 | $193K | Buy |
4,160
+2,433
| +141% | +$113K | ﹤0.01% | 1307 |
|
2023
Q4 | $82K | Sell |
1,727
-1,763
| -51% | -$83.7K | ﹤0.01% | 1741 |
|
2023
Q3 | $123K | Buy |
3,490
+1,900
| +119% | +$67K | ﹤0.01% | 1553 |
|
2023
Q2 | $73K | Sell |
1,590
-1,320
| -45% | -$60.6K | ﹤0.01% | 1698 |
|
2023
Q1 | $115K | Buy |
2,910
+332
| +13% | +$13.1K | ﹤0.01% | 1480 |
|
2022
Q4 | $118K | Buy |
2,578
+279
| +12% | +$12.8K | ﹤0.01% | 1465 |
|
2022
Q3 | $95K | Buy |
2,299
+1,366
| +146% | +$56.4K | ﹤0.01% | 1496 |
|
2022
Q2 | $54K | Buy |
933
+37
| +4% | +$2.14K | ﹤0.01% | 1777 |
|
2022
Q1 | $64K | Buy |
896
+240
| +37% | +$17.1K | ﹤0.01% | 1622 |
|
2021
Q4 | $54K | Buy |
656
+117
| +22% | +$9.63K | ﹤0.01% | 1705 |
|
2021
Q3 | $48K | Sell |
539
-1,000
| -65% | -$89.1K | ﹤0.01% | 1704 |
|
2021
Q2 | $145K | Buy |
1,539
+796
| +107% | +$75K | ﹤0.01% | 1264 |
|
2021
Q1 | $84K | Hold |
743
| – | – | ﹤0.01% | 1250 |
|
2020
Q4 | $102K | Buy |
743
+16
| +2% | +$2.2K | ﹤0.01% | 1180 |
|
2020
Q3 | $59K | Sell |
727
-354
| -33% | -$28.7K | ﹤0.01% | 1135 |
|
2020
Q2 | $84K | Sell |
1,081
-754
| -41% | -$58.6K | ﹤0.01% | 1065 |
|
2020
Q1 | $81K | Buy |
1,835
+1,401
| +323% | +$61.8K | ﹤0.01% | 1044 |
|
2019
Q4 | $18K | Buy |
434
+179
| +70% | +$7.42K | ﹤0.01% | 1260 |
|
2019
Q3 | $10K | Buy |
+255
| New | +$10K | ﹤0.01% | 1306 |
|
2017
Q2 | – | Sell |
-24,225
| Closed | -$1.64M | – | 1041 |
|
2017
Q1 | $1.64M | Sell |
24,225
-525
| -2% | -$35.6K | ﹤0.01% | 673 |
|
2016
Q4 | $1.74M | Hold |
24,750
| – | – | ﹤0.01% | 637 |
|
2016
Q3 | $1.76M | Hold |
24,750
| – | – | ﹤0.01% | 633 |
|
2016
Q2 | $1.21M | Hold |
24,750
| – | – | ﹤0.01% | 670 |
|
2016
Q1 | $1.57M | Sell |
24,750
-840
| -3% | -$53.1K | ﹤0.01% | 637 |
|
2015
Q4 | $2.87M | Sell |
25,590
-2,060
| -7% | -$231K | 0.01% | 603 |
|
2015
Q3 | $2.66M | Buy |
+27,650
| New | +$2.66M | 0.01% | 568 |
|